Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases

A new treatment option for cluster headache (CH) prevention is needed. Monoclonal antibodies (mABs) against calcitonin gene-related peptide (CGRP) ligands are used as a preventative treatment for migraine. Considering the CGRP’s role in the CH attack’s ignition and upkeep, fremanezumab and galcanezu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Kenta, Katsuki, Masahito, Kawamura, Shin, Tachikawa, Senju, Ono, Atsuko, Koh, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057600/
https://www.ncbi.nlm.nih.gov/pubmed/36976663
http://dx.doi.org/10.3390/neurolint15010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057600/
https://www.ncbi.nlm.nih.gov/pubmed/36976663
http://dx.doi.org/10.3390/neurolint15010020

Ejemplares similares